CRSP icon

CRISPR Therapeutics
CRSP

Overview Fund Activity

395 hedge funds and large institutions have $2.45B invested in CRISPR Therapeutics in 2022 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 117 increasing their positions, 120 reducing their positions, and 87 closing their positions.

Holders
395
Holders Change
-39
Holders Change %
-8.99%
% of All Funds
6.37%
Holding in Top 10
3
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-62.5%
% of All Funds
0.05%
New
56
Increased
117
Reduced
120
Closed
87
Calls
$109M
Puts
$86.2M
Net Calls
+$23.2M
Net Calls Change
+$12.7M

Top Buyers

1
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$122M
2
State Street
2
State Street
Massachusetts
$84.6M
3
BlackRock
3
BlackRock
New York
$107M
4
Barclays
4
Barclays
United Kingdom
$15.8M
5
PI
5
PEAK6 Investments
Illinois
$11.1M

Top Sellers

1
AWA
1
Arete Wealth Advisors
Illinois
$230M
2
Bank of America
2
Bank of America
North Carolina
$17.3M
3
Macquarie Group
3
Macquarie Group
Australia
$1.62M
4
AIM
4
ARK Investment Management
Florida
$318M
5
IHAM
5
Integral Health Asset Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
GWSG
476
GPS Wealth Strategies Group
Colorado
– -$2K -25 Closed
SWA
477
SOA Wealth Advisors
New York
– -$1K -18 Closed
SWM
478
Sugarloaf Wealth Management
Georgia
– -$1K -10 Closed
MA
479
MUFG Americas
New York
– -$1K -10 Closed
CSB
480
City State Bank
Iowa
– -$1K -10 Closed
FWA
481
FSC Wealth Advisors
New York
– -$1K -10 Closed
16 17 18 19
20